about
Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminaseMutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificitiesRole and mechanism of action of the APOBEC3 family of antiretroviral resistance factorsLong non-coding RNAs in nervous system function and diseaseCrystal structure of the APOBEC3G catalytic domain reveals potential oligomerization interfacesAPOBEC3G contributes to HIV-1 variation through sublethal mutagenesisPatterns of evolution of host proteins involved in retroviral pathogenesis.The APOBEC3 family of retroelement restriction factorsPopulation genomic analysis reveals a rich speciation and demographic history of orang-utans (Pongo pygmaeus and Pongo abelii)Footprint of APOBEC3 on the genome of human retroelementsEvolution and divergence of the mammalian SAMD9/SAMD9L gene familyIntrinsic immunity against retrotransposons by APOBEC cytidine deaminasesEvolutionary dynamics of the interferon-induced transmembrane gene family in vertebratesAn ancient history of gene duplications, fusions and losses in the evolution of APOBEC3 mutators in mammalsVpu and BST2: Still Not There Yet?Convergent evolution of escape from hepaciviral antagonism in primatesHIV and SIV infection: the role of cellular restriction and immune responses in viral replication and pathogenesisAPOBEC3G: an intracellular centurionPositive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domainParadigm development: comparative and predictive 3D modeling of HIV-1 Virion Infectivity Factor (Vif).Cellular inhibitors of long interspersed element 1 and Alu retrotransposition.The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals.Are viruses inhibited by APOBEC3 molecules from their host species?Positive selection of HIV host factors and the evolution of lentivirus genesMolecular evolution of the primate antiviral restriction factor tetherinFeline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast.Selective inhibition of Alu retrotransposition by APOBEC3G.Positive selection for indel substitutions in the rodent sperm protein catsper1.Local sequence targeting in the AID/APOBEC family differentially impacts retroviral restriction and antibody diversification.Characterization of the relationship between APOBEC3B deletion and ACE Alu insertion.High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition.Crystal structure of DNA cytidine deaminase ABOBEC3G catalytic deamination domain suggests a binding mode of full-length enzyme to single-stranded DNA.Natural selection among Eurasians at genomic regions associated with HIV-1 controlTrans genomic capture and sequencing of primate exomes reveals new targets of positive selection.APOBEC3G levels predict rates of progression to AIDSInduction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons.Emerging complexities of APOBEC3G action on immunity and viral fitness during HIV infection and treatment.Understanding restriction factors and intrinsic immunity: insights and lessons from the primate lentiviruses.Inhibition of alpharetrovirus replication by a range of human APOBEC3 proteins
P2860
Q21131577-271321D1-490A-48BA-BB7C-2CA11E59BFC3Q24521469-F88A99B3-E941-4BF7-9DC4-5C1583782745Q24537623-CC60F831-53C4-4C09-BCDC-A052C2D56F1CQ24595656-A3FCF78B-AD72-49D7-8E38-5A1D4B79CFE5Q24599263-3C3177A1-EB78-4F76-B361-E95E81B385F7Q24618320-DF66F364-EF14-49DC-A184-C053C09B02C0Q25257040-734B335F-1D83-4EFC-8618-D642239D084AQ26862780-BC16D248-E8AA-4C2B-B971-29A2F123FC9FQ28662181-B4EAF130-C62A-4EF9-8657-CCC287F56D92Q28680708-5B5C59B3-DDEF-46DC-904C-3C5D093003C3Q28681331-856A4C13-ED15-4BF5-AC81-3485D5802ECDQ28708757-6343EF6F-DED2-4DFA-8B3D-7DB6949B1C95Q28712012-FC20C89D-4770-420F-BCD1-28CFEECFE0A5Q28713968-92DACA25-11E4-42F4-9693-983FBA2036F5Q28730708-A084A804-7063-4A9A-A6D0-A0448581311BQ28731324-38CA7EC3-B542-461B-BF52-95114D6CAF98Q28751706-DBB8C2E4-62D0-4DE2-8EF9-C036B1A36930Q28754989-50713588-B011-42DA-83A4-C37B4182FB37Q29618741-19BA3C1E-791E-4987-963A-B55A1F176C89Q30362641-AA5977BC-2D4F-4812-8288-B4DFF4CAE5E2Q30445599-18884CBF-A0BE-4920-8A3A-83AA4FC03F5EQ33385376-2370C756-57B1-41F3-AFB1-27BE3C6BA5E8Q33434458-80D876BF-7191-43F8-A576-DD2D5134352EQ33611114-C984FE11-25DC-4A76-AFC5-BAF2D6E10C23Q33650914-3033B93E-AC5D-4AF3-ABE3-C62FA00A8287Q33690901-307ABF63-EF00-4251-BE28-CFB405CB9620Q33892198-9C21F999-C29A-46C7-BD95-EC7FFA68C99EQ34048853-BD202B72-F87B-4F00-9F16-6DC1AAF3AD22Q34314153-420F534A-BEA2-4BF5-9893-172D45D32D23Q34412763-54238BDD-9878-4D52-8BA4-6EBEE34106C2Q34746372-A455AC66-584D-47C4-A932-E81BC2443AC8Q35070356-0DE84476-47C0-4E3D-8074-0658C1E4EEDCQ35080239-18E5BEBC-958F-418B-B3C6-404109C99A56Q35121407-F66A3605-EAFE-42D5-9114-21D89B70E418Q35451815-EF045D08-5645-4768-BA9C-FA1BA4438B23Q35699707-7C2B35A6-D4A1-41B1-B55B-0BFE71E9E262Q36099079-DE4ACCAE-8E8E-4220-8565-B1C39D8AB024Q36156679-F3464F65-3A63-48E4-8AD6-046E0F897710Q36242717-6B045059-F877-437F-9DB7-77B618FC1D11Q36315179-16D54017-F447-4214-AB8E-987650C66DE2
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Rapid evolution of primate antiviral enzyme APOBEC3G.
@en
Rapid evolution of primate antiviral enzyme APOBEC3G.
@nl
type
label
Rapid evolution of primate antiviral enzyme APOBEC3G.
@en
Rapid evolution of primate antiviral enzyme APOBEC3G.
@nl
prefLabel
Rapid evolution of primate antiviral enzyme APOBEC3G.
@en
Rapid evolution of primate antiviral enzyme APOBEC3G.
@nl
P356
P1476
Rapid evolution of primate antiviral enzyme APOBEC3G.
@en
P2093
David M Webb
Jianzhi Zhang
P304
P356
10.1093/HMG/DDH183
P577
2004-06-15T00:00:00Z